SUNGAI PETANI (Jan 30): The country’s first batch of 62 volunteers received their jabs for the Covid-19 vaccine phase three clinical trials at the Sultan Abdul Halim Hospital (HSAH) here today.
HSAH Clinical Research Centre (CRC) head Dr SL Vijaya Kumar said the volunteers were from various backgrounds, aged 18 and above and healthy.
“We have targeted 375 volunteers for the trials and this programme will be carried out in stages over a period of one month.
“Each volunteer will receive two jabs. After the first jab, they will be monitored each week for six weeks to see if there are any adverse effects,” he told reporters at the HSAH today.
Saturday, 30 Jan 2021 07:34 PM MYT
Health Minister Datuk Seri Dr Adham Baba announced the commencement of the Covid-19 vaccine phase three clinical trials, involving 3,000 volunteers, in nine hospitals. Picture by Hari Anggara
Subscribe to our Telegram channel for the latest updates on news you need to know.
SUNGAI PETANI, Jan 30 The country’s first batch of 62 volunteers received their jabs for the Covid-19 vaccine phase three clinical trials at the Sultan Abdul Halim Hospital (HSAH) here today.
HSAH Clinical Research Centre (CRC) head Dr S.L. Vijaya Kumar said the volunteers were from various backgrounds, aged 18 and above and healthy.
“We have targeted 375 volunteers for the trials and this programme will be carried out in stages over a period of one month.
Published on: Saturday, January 30, 2021
By: Bernama
Photo: Bernama
SUNGAI PETANI: The country’s first batch of 62 volunteers received their jabs for the COVID-19 vaccine phase three clinical trials at the Sultan Abdul Halim Hospital (HSAH) here today.
HSAH Clinical Research Centre (CRC) head Dr S.L. Vijaya Kumar said the volunteers were from various backgrounds, aged 18 and above and healthy.
“We have targeted 375 volunteers for the trials and this programme will be carried out in stages over a period of one month.
ADVERTISEMENT
“Each volunteer will receive two jabs. After the first jab, they will be monitored each week for six weeks to see if there are any adverse effects,” he told reporters at the HSAH today.
GSK ocupa el primer puesto del Índice de Acceso a los Medicamentos de 2021 con una línea de investigación pionera para enfermedades prioritarias pmfarma.es - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmfarma.es Daily Mail and Mail on Sunday newspapers.